Higher Buprenorphine Doses Reduce Acute Care for Opioid Use Disorder
By Lori Solomon HealthDay Reporter
WEDNESDAY, Oct. 2, 2024 -- Higher doses of buprenorphine for patients with opioid use disorder (OUD) are associated with lower acute care utilization, according to a study published online Sept. 25 in JAMA Network Open.
Sarah Axeen, Ph.D., from the University of Southern California in Los Angeles, and colleagues examined the association between higher buprenorphine doses (above 16 mg and 24 mg) and subsequent emergency department or inpatient service use among patients diagnosed with OUD. The analysis included 35,451 individuals with commercial insurance and an OUD diagnosis (2016 to 2021) who began buprenorphine treatment.
The researchers found that the most common dose was >8 to 16 mg daily (42.9 percent), with 27.3 percent in the 1- to 8-mg tier, 29 percent in the 16- to 24-mg tier, and 1.8 percent receiving >24 mg. Overall, 12.5 percent of patients receiving buprenorphine experienced an emergency department or inpatient visit. Patients receiving doses >24 mg and 16 to 24 mg had longer times to emergency department or inpatient use than patients receiving 8 to 16 mg (time ratio [TR], 1.37 and 1.11, respectively). Findings for doses >16 mg daily persisted for observation windows as short as 365 days (>24 mg: TR, 1.48; >16 to 24 mg: TR, 1.19).
"These results suggest that higher doses of buprenorphine are associated with lower acute care utilization and could provide benefits to patients, particularly those using fentanyl who might need these higher doses," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Previous Estimates of Illicit Opioid Use in the United States Underreported
WEDNESDAY, May 14, 2025 -- Illicit opioid use may be higher than previously reported in the United States, according to a study published online May 9 in JAMA Health...
Rates of Fentanyl Nonfatal Overdose ED Visits Rose Through Third Quarter of 2023
WEDNESDAY, May 14, 2025 -- From 2020 to 2023, there was an increase in the rates of fentanyl-involved nonfatal overdose emergency department visits, according to research...
Nearly 19 Million Children Live Under Same Roof as Parent With Substance Use Disorder
TUESDAY, May 13, 2025 -- In 2023, nearly 19 million children in the United States were estimated to be living in a household with at least one parent or primary caregiver with a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.